Magnetic resonance imaging in moyamoya disease
Related Experiment Videos
Journal of Child Neurology
|January 1, 1986
Abstract:
Magnetic resonance imaging of the brain in a patient with moyamoya disease demonstrated multiple scattered white matter lesions, but was not sufficiently specific to confirm the diagnosis without other techniques.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multiple sclerosis treatment 2001.
Neurologic clinics·2001
Cardiac risk stratification of patients with symptomatic spinal stenosis.
Clinical orthopaedics and related research·2001
Migraine versus multiple sclerosis.
Headache·2001
Two-dimensional echocardiography and Doppler ultrasound in managing obstetric patients.
Obstetrics and gynecology·1997
Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy.
Thyroid : official journal of the American Thyroid Association·1996
Applying a Health Equity Lens to Pediatric Neurology Research: Lessons Learned From an Educational Workshop.
Journal of child neurology·2026
Phenylbutyrate-Responsive SLC6A1-Related Neurodevelopmental Disorder Associated With a Familial Variant.
Journal of child neurology·2026
Caring Across Languages: Clinician Perceptions of Variability in US Pediatric Outpatient Epilepsy Care.
Journal of child neurology·2026
Malignant Intracranial Pressure Elevation in MOGAD Meningoencephalitis.
Journal of child neurology·2026
MONKEY Challenge: Machine-learning for Optimal detection of iNflammatory cells in KidnEY transplant biopsies.
Laboratory investigation; a journal of technical methods and pathology·2026
Dynamic ring rearrangements underlie transport by MCE proteins.
Structure (London, England : 1993)·2026
Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia.
The American journal of emergency medicine·2026
Real-world safety outcomes of COVID-19 mRNA vaccine: A result from Korea post-marketing surveillance.
Human vaccines & immunotherapeutics·2026